
Richter Signs Development Agreement for Weight Loss Jab
Gedeon Richter Plc. and Adalvo, a pharmaceutical company, have entered into a strategic joint development and licensing agreement for the development of Semaglutide injection, an active ingredient used for weight loss treatment. They announced that the …